Enter your terms above and click the 'Search' button.

Showing articles 0 to 15 of 15 Filter Applied: complications (Click to remove) Infectious Mononucleosis: Rapid Evidence Review Am Fam Physician 107:71-78, Sylventer,J.E.,et al, 2023 Duchenne Muscular Dystrophy BMJ 368:L7012, Fox, H.,et al, 2020 Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy NEJM 381:275-283, Case 22-2019, 2019 Hemophagocytic Lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab Neurol 90:849-851, Saarela, M.,et al, 2018 Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy Neurol 91:e359-e363, Rauer,S.,et al, 2018 Metronidazole-Associated Encephalopathy NEJM 374:1465, Baden, L.R., 2016 Brugada Syndrome in Spinal and Bulbar Muscular Atrophy Neurol 82:1813-1821, Araki, A.,et al, 2014 Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis NEJM 366:1000-1009, Comi,G.,et al, 2012 Apixaban in Patients With Atrial Fibrillation NEJM 364:806-817, Connolly,S.J.,et al, 2011 Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011 Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome) UpToDate, Feb, Shovlin, C., 2011 Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010 A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis NEJM 362:387-401, 456, Kappos, L.,et al, 2010 Rifaximin Treatment in Hepatic Encephalopathy NEJM 362:1071-1081, 1140, Bass,N.M.,et al, 2010 Levetiracetam as a Possible Cause of Fulminant Liver Failure Neurol 71:685-686, Tan,T.C.H.,et al., 2008 Showing articles 0 to 15 of 15